Dashboard
Manage Tickers

HIMSHims & Hers Health, Inc.

NYSE forhims.com


$ 16.29 $ -0.29 (-1.75 %)    

Monday, 16-Sep-2024 15:59:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 473.14 $ -2.10 (-0.44 %)
DIA $ 417.33 $ 2.44 (0.59 %)
SPY $ 562.48 $ 0.83 (0.15 %)
TLT $ 101.29 $ 0.92 (0.92 %)
GLD $ 238.61 $ -0.02 (-0.01 %)
$ 16.28
$ 16.46
$ 15.50 x 100
-- x --
$ 16.15 - $ 16.67
$ 5.65 - $ 25.74
4,862,988
na
3.6B
$ 0.90
$ 199.18
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-05-2024 06-30-2024 10-Q
2 05-06-2024 03-31-2024 10-Q
3 02-26-2024 12-31-2023 10-K
4 11-06-2023 09-30-2023 10-Q
5 08-07-2023 06-30-2023 10-Q
6 05-08-2023 03-31-2023 10-Q
7 02-27-2023 12-31-2022 10-K
8 11-07-2022 09-30-2022 10-Q
9 08-08-2022 06-30-2022 10-Q
10 05-09-2022 03-31-2022 10-Q
11 02-24-2022 12-31-2021 10-K
12 11-10-2021 09-30-2021 10-Q
13 08-11-2021 06-30-2021 10-Q
14 05-17-2021 03-31-2021 10-Q
15 03-22-2021 12-31-2020 10-K
16 11-13-2020 09-30-2020 10-Q
17 08-13-2020 06-30-2020 10-Q
18 05-14-2020 03-31-2020 10-Q
19 03-27-2020 12-31-2019 10-K
20 11-12-2019 09-30-2019 10-Q
21 08-29-2019 06-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

deep-dive-into-hims--hers-health-stock-analyst-perspectives-8-ratings
Deep Dive Into Hims & Hers Health Stock: A...
09/13/2024 17:00:34

b-of-a-securities-maintains-buy-on-hims--hers-health-lowers-price-target-to-20
B of A Securities Maintains Buy on Hims & ...
09/13/2024 16:52:46

B of A Securities analyst Michael Cherny maintains Hims & Hers Health (NYSE:HIMS) with a Buy and lowers the price target...

novo-nordisk-reports-positive-results-of-weight-loss-drug-liraglutide-for-children-as-young-as-6-eyes-fda-and-ema-approval
Novo Nordisk Reports Positive Results Of W...
09/11/2024 08:19:30

Novo Nordisk has announced that its weight-loss drug liraglutide is safe and effective for children as young as six. The compan...

hims--hers-health-inc-files-for-mixed-shelf-offering-size-not-disclosed
Hims & Hers Health Inc. Files For Mixed Sh...
09/09/2024 20:04:25

- SEC Filing

battle-over-compounded-weight-loss-medications---sustainability-and-regulation
Battle Over Compounded Weight-Loss Medicat...
09/05/2024 16:47:47

Explore how Hims & Hers competes with big pharma amid weight-loss drug shortages, offering cheaper alternatives and facing ...

Core News & Articles
MHRA Finds No Evidence Supporting Link Bet...
09/04/2024 14:52:07

- Reuters 

hearing-blog-post-capitol-forum-reports-former-pharmacists-raise-concerns-over-patient-safety-and-compounding-practices-at-hims--hers-health
Hearing Blog Post; Capitol Forum Reports F...
08/29/2024 19:09:36

why-hims--hers-health-stock-is-falling
Why Hims & Hers Health Stock Is Falling
08/27/2024 14:54:44

Eli Lilly's launch of the competitively priced Zepbound has triggered a 4.9% drop in Hims & Hers' stock. This has r...

american-woodmark-reports-downbeat-results-joins-snowflake-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session
American Woodmark Reports Downbeat Results...
08/27/2024 12:12:10

hims--hers-health-sees-major-growth-opportunity-in-booming-weight-loss-market-says-analyst
Hims & Hers Health Sees Major Growth Oppor...
08/22/2024 18:26:20

Needham analyst initiates coverage on Hims & Hers Health, Inc. with a Buy rating and $24 price target. Anticipates positive...

the-latest-analyst-ratings-for-hims--hers-health
The Latest Analyst Ratings For Hims & Hers...
08/22/2024 14:00:22

hims--hers-health-shares-are-trading-higher-after-needham-initiated-coverage-on-the-stock-with-a-buy-rating-and-announced-a-price-target-of-24
Hims & Hers Health shares are trading high...
08/22/2024 12:55:24

needham-initiates-coverage-on-hims--hers-health-with-buy-rating-announces-price-target-of-24
Needham Initiates Coverage On Hims & Hers ...
08/22/2024 11:01:36

Needham analyst Ryan MacDonald initiates coverage on Hims & Hers Health (NYSE:HIMS) with a Buy rating and announces Pric...

looking-into-hims--hers-healths-recent-short-interest
Looking Into Hims & Hers Health's Recent S...
08/19/2024 19:15:18

telehealth-firm-hims--hers-health-rides-high-on-demand-for-copycat-weight-loss-drugs-amid-supply-shortages
Telehealth Firm Hims & Hers Health Rides H...
08/19/2024 13:24:02

Hims & Hers Health has seen its stock rise over 120% due to soaring demand for its affordable compounded GLP-1 weight-loss ...

hims--hers-health-unusual-options-activity-for-august-13
Hims & Hers Health Unusual Options Activit...
08/13/2024 15:47:11

deutsche-bank-maintains-hold-on-hims--hers-health-raises-price-target-to-23
Deutsche Bank Maintains Hold on Hims & Her...
08/07/2024 17:31:07

Deutsche Bank analyst George Hill maintains Hims & Hers Health (NYSE:HIMS) with a Hold and raises the price target from ...

analyst-expectations-for-hims--hers-healths-future
Analyst Expectations For Hims & Hers Healt...
08/06/2024 20:01:49

piper-sandler-reiterates-neutral-on-hims--hers-health-maintains-18-price-target
Piper Sandler Reiterates Neutral on Hims &...
08/06/2024 17:51:38

Piper Sandler analyst Korinne Wolfmeyer reiterates Hims & Hers Health (NYSE:HIMS) with a Neutral and maintains $18 price...

Core News & Articles
Top 10 Trending Stocks On WallStreetBets A...
08/06/2024 13:19:31

NVDAWAYINTCAAPLMADELOTHIMSPLTRQQQTSLAData from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment  NVDAWAYINTCA...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION